No Data
Express News | Tandem Diabetes Care Prices Upsized Private Placement Of $265M Convertible Senior Notes Due 2032 At $36.99 Conversion Price Per Share
Express News | Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032
A Quick Look at Today's Ratings for Tandem Diabetes Care(TNDM.US), With a Forecast Between $27 to $50
Tandem Diabetes Price Target Raised to $35 From $30 at BofA
Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR), Tandem Diabetes Care (TNDM) and Hims & Hers Health (HIMS)
Express News | Tandem Diabetes Care Inc : BofA Global Research Raises Price Objective to $35 From $30